# Assessment of the Clinical and Ultrasound Response to Apremilast by Clinical Evaluation and by a Joint-periarticular-nail Ultrasound Index in Patients With Active Psoriatic Arthritis

> **NCT03191539** · PHASE3 · UNKNOWN · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 56 (estimated)

## Conditions studied

- Arthritis; Psoriasis (Etiology)

## Interventions

- **DRUG:** Apremilast

## Key facts

- **NCT ID:** NCT03191539
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-02
- **Primary completion:** 2019-06-14
- **Final completion:** 2019-06-14
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2017-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03191539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03191539, "Assessment of the Clinical and Ultrasound Response to Apremilast by Clinical Evaluation and by a Joint-periarticular-nail Ultrasound Index in Patients With Active Psoriatic Arthritis". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT03191539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*